| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Greenwich Lifesciences, Inc. (GLSI) has 1 insider with recent SEC Form 4 filings, including 10 buys and 0 sells. GLSI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 5.60M | $128.53M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 4, 2023 | Patel Snehal | CEO And CFO | Buy | 2,000 | $8.63 | $17,260.00 | - | |
| Sep 26, 2023 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 600 | $8.71 | $5,226.00 | +0.2% | |
| Sep 19, 2023 | Patel Snehal | CEO And CFO | Buy | 4,000 | $8.95 | $35,800.00 | - | |
| Sep 11, 2023 | Patel Snehal | CEO And CFO | Buy | 1,000 | $9.48 | $9,480.00 | - | |
| Aug 22, 2023 | Patel Snehal | CEO And CFO | Buy | 1,000 | $9.97 | $9,970.00 | - | |
| Aug 4, 2023 | Patel Snehal | CEO And CFO | Buy | 2,000 | $10.55 | $21,100.00 | - | |
| Jul 21, 2023 | Patel Snehal | CEO And CFO | Buy | 1,000 | $9.20 | $9,200.00 | - | |
| Jul 13, 2023 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 250 | $9.49 | $2,372.50 | - | |
| May 17, 2023 | Patel Snehal | CEO And CFO | Buy | 1,000 | $11.69 | $11,690.00 | - | |
| Apr 28, 2023 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 250 | $11.22 | $2,805.00 | - |